278 related articles for article (PubMed ID: 15524008)
1. [Clinical effectiveness of synergic therapy].
Płusa T; Lubiński W
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():20-2. PubMed ID: 15524008
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of combined treatment with corticosteroids and beta2 agonists in adults with asthma].
ten Hacken NH; Kerstjens HA; Postma DS
Ned Tijdschr Geneeskd; 2006 Apr; 150(16):892-7. PubMed ID: 16686088
[TBL] [Abstract][Full Text] [Related]
3. Current trends in asthma therapy.
Sztanke K; Pasternak K
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):290-3. PubMed ID: 15323207
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
5. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
Ankerst J
J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
[TBL] [Abstract][Full Text] [Related]
6. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
[TBL] [Abstract][Full Text] [Related]
7. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
8. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
9. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
Gordon E; Lazarus SC
J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
[TBL] [Abstract][Full Text] [Related]
10. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
[TBL] [Abstract][Full Text] [Related]
11. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
Gillissen A; Gessner C; Hoheisel G; Juergens U
Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
[TBL] [Abstract][Full Text] [Related]
12. Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease.
Wang ZL
Chin Med J (Engl); 2007 Jun; 120(12):1097-105. PubMed ID: 17637229
[No Abstract] [Full Text] [Related]
13. "As-required" combination therapy with inhaled corticosteroids and long-acting beta-2 agonists for asthma: current evidence and recommendations.
Taylor DR; Jayaram L; Asher MI; Epton MJ
N Z Med J; 2008 Nov; 121(1285):106-18. PubMed ID: 19079443
[TBL] [Abstract][Full Text] [Related]
14. Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
Sin DD; Man SF
Curr Opin Pulm Med; 2007 Mar; 13(2):90-7. PubMed ID: 17255798
[TBL] [Abstract][Full Text] [Related]
15. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
Wise RA; Tashkin DP
Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
[TBL] [Abstract][Full Text] [Related]
16. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
Hanania NA
Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
[TBL] [Abstract][Full Text] [Related]
17. A safety review of long-acting beta2-agonists in patients with asthma.
Rider NL; Craig TJ
J Am Osteopath Assoc; 2006 Sep; 106(9):562-7. PubMed ID: 17079526
[TBL] [Abstract][Full Text] [Related]
18. [Corticosteroid treatment in airways narrowing].
Chazan R
Pneumonol Alergol Pol; 2008; 76(2):96-100. PubMed ID: 18464224
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
Gagnon YM; Levy AR; Spencer MD; Hurley JS; Frost FJ; Mapel DW; Briggs AH
Respir Med; 2005 Dec; 99(12):1534-45. PubMed ID: 16291076
[TBL] [Abstract][Full Text] [Related]
20. In vitro synergism of inhaled corticosteroid and long-acting beta2-agonist is not translated clinically in vivo.
Lee DK; Currie GP; Lipworth BJ
J Allergy Clin Immunol; 2005 Apr; 115(4):880; author reply 880-1. PubMed ID: 15806018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
